Kathleen Tregoning - 06 Jul 2026 Form 4 Insider Report for Kailera Therapeutics, Inc. (KLRA)

Reporting relationship: Chief Corporate Affairs Officer
Issuer ticker: KLRA
Reported as of: 06 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jul 2026, 16:20:04 UTC
Prior SEC filing: 08 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ John Mei, Attorney-in-fact

Key filing fact

Kathleen Tregoning filed Form 4 for Kailera Therapeutics, Inc. (KLRA) on 08 Jul 2026.

Key facts

This page summarizes Kathleen Tregoning's Form 4 filing for Kailera Therapeutics, Inc. (KLRA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Jul 2026, 16:20.

Change

Previous filing in this sequence was filed on 08 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001830764 Primary reporting owner

Tregoning Kathleen

Relationship: Chief Corporate Affairs Officer
Address: C/O KAILERA THERAPEUTICS, INC., 180 THIRD AVENUE, 4TH FLOOR, WALTHAM
Signature: /s/ John Mei, Attorney-in-fact
Signature date: 08 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KLRA transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +175,000
Change %
Price: $0.000000^*
Shares after: 175,000
Date: 06 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 175,000
Exercise price: $23.30
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest and become exercisable as to 25% of the underlying shares on June 29, 2027 and thereafter in 36 substantially equal monthly installments, subject to the Reporting Person's continued service through each such vesting date.

SEC remarks

Chief Corporate Affairs Officer